1 / 4

Program Name

This document serves as a comprehensive briefer for the program, providing essential information on decision-making and informational aspects. It outlines key components such as ACAT Level, DOT&E oversight, testing stages, and operational test activities. The brief includes recommendations based on COI resolutions, effectiveness and suitability determinations, and identifies any changes from E-SERB results, including added OPCON or risk changes. Additional programmatic details will be provided for stakeholders to ensure informed decision-making.

havily
Télécharger la présentation

Program Name

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. UNCLASSIFIED Program Name Decisional / Informational (select one) Document Name Date Briefer / Code UNCLASSIFIED

  2. BLUF (Bottom Line up front) • Informational / Decisional • Signature Needed • Message Release • Et cetera

  3. Basic Information • ACAT Level • DOT&E Oversight • Testing Stage (ie. Pre-Milestone C) • OTD/OTC Names • PMA-XXX • MDA • Prime Contractor • Operational Test Activity (ie. VX-1) • If a Joint Program, who is the Lead OTA? • Other pertinent programmatic information • Is Program developing an OT Framework? • Is Program conducting IT?

  4. Continue PPT brief as you see fit for your program / issues. • For final report briefs, include • summary of COI resolutions with summary of risks/deficiencies under each COI. • Changes from E-SERB results (ie, added OPCON or deficiency/risk change with rationale) • Effectiveness Suitability determination • Overall recommendation

More Related